ALL News

45newscente
Area
Topic
SearchYour SelectionClear All
Your Selection
Clear All
5b90d94075bb1
Challenging third quarter – Group outlook confirmed
edeecadac5260901c22ce34e9707f53
Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel diabetes treatment dorzagliatin in China
未标題-2
Chiesi Group and Bayer announce co-promotion agreement for respiratory treatments Clenil and Foster in China
5b90d94075bb1
Bayer partners with MassBio to launch joint mentoring program to support startups in China and Asia
5b90d94075bb1
Bayer and WaveForm Technologies Inc. to provide continuous glucose monitoring solutions for patients in China
5b90d94075bb1
Multiple micronutrient supplementation plays a vial important role to reduce the risk of adverse pregnancy outcomes
5b90d94075bb1
Fiscal 2019:Bayer strategically and operationally successful
5b90d94075bb1
Bayer and WuXi Biologics enter into an agreement on a Leverkusen drug